Adherence to Hepatitis C Treatment Among Underserved Patients With Substance Use Disorder in a Pharmacist-led Treatment Model
Journal of Pharmacy Practice · 2024
DOI: 10.1177/08971900231165172 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy Practice, 2024. Verfasst von Anthony J McKenzie und 4 weiteren Autor:innen. Beteiligte Einrichtung: PGY2 Ambulatory Care Pharmacy Resident, Pharmacy Services, Family Medicine at Richmond Clinic, Oregon Health & Science University, Portland, OR, USA. Hauptthemen laut MEDLINE: Pharmacists, Medication Adherence, Hepatitis C, Antiviral Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Background
Treatment with medications for opioid use disorder (MOUD) may improve hepatitis C virus (HCV) treatment outcomes by providing additional contact with health care professionals to support patient engagement.
Objective
We describe a pharmacist-led HCV treatment model and assessed the effect of MOUD on adherence to direct-acting antivirals (DAAs) in an underserved patient population.
Methods
This was a retrospective cohort study of adults (age≥18 years) treated for HCV infection with DAAs at a Federally Qualified Health Center in Portland, Oregon, between March 1, 2019, and March 16, 2020. Patients were followed to 12 weeks to assess adherence to DAAs by MOUD status.
Results
Among 59 eligible patients, 16 (27%) were prescribed MOUD. Baseline characteristics were similar between patients who did and did not receive MOUD. Adherence to DAAs was overall high and not significantly different between the groups (median: 98.5% vs median: 100%; P = .06). Five patients missed at least one dose due to an adverse drug effect and two of these patients discontinued HCV therapy due to these effects.
Conclusion
Adherence to HCV therapy was nearly 100% among underserved patients in a pharmacist-led HCV treatment model and did not differ by MOUD engagement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- PGY2 Ambulatory Care Pharmacy Resident, Pharmacy Services, Family Medicine at Richmond Clinic, Oregon Health & Science University, Portland, OR, USA.
- Senior Faculty Research Assistant, Department of Pharmacy Practice, Oregon State University College of Pharmacy, Portland, OR, USA.
- Clinical Associate Professor, Department of Pharmacy Practice, Oregon State University College of Pharmacy, Portland, OR, USA.
- Pharmacy Operations Manager Family Medicine at Richmond Clinic, Oregon Health & Science University, Portland, OR, USA.
- Professor, Department of Pharmacy Practice, Oregon State University College of Pharmacy, Portland, OR, USA.
ORCID-Profile: Jon P Furuno
Zitieren
APA
McKenzie, A. J., Noble, B. N., Herink, M. C., Viehmann, M. M., & Furuno, J. P. (2024). Adherence to Hepatitis C Treatment Among Underserved Patients With Substance Use Disorder in a Pharmacist-led Treatment Model. Journal of Pharmacy Practice. https://doi.org/10.1177/08971900231165172
Vancouver
McKenzie AJ, Noble BN, Herink MC, Viehmann MM, Furuno JP. Adherence to Hepatitis C Treatment Among Underserved Patients With Substance Use Disorder in a Pharmacist-led Treatment Model. Journal of Pharmacy Practice. 2024. doi:10.1177/08971900231165172
BibTeX
@article{McKenzie2024,
author = {McKenzie, Anthony J and Noble, Brie N and Herink, Megan C and Viehmann, Megan M and Furuno, Jon P},
title = {Adherence to Hepatitis C Treatment Among Underserved Patients With Substance Use Disorder in a Pharmacist-led Treatment Model},
journal = {Journal of Pharmacy Practice},
year = {2024},
doi = {10.1177/08971900231165172}
}
EUVIMED